Curanex Pharmaceuticals (NASDAQ:CURX) Trading 6.8% Higher – Time to Buy?

Curanex Pharmaceuticals Inc (NASDAQ:CURX)’s stock price was up 6.8% on Monday . The company traded as high as $0.4209 and last traded at $0.41. Approximately 371,407 shares changed hands during trading, a decline of 97% from the average daily volume of 12,962,110 shares. The stock had previously closed at $0.3840.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CURX. Weiss Ratings reiterated a “sell (e-)” rating on shares of Curanex Pharmaceuticals in a report on Monday, December 29th. Wall Street Zen cut shares of Curanex Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Saturday, November 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Curanex Pharmaceuticals Stock Up 6.8%

The business has a fifty day moving average of $0.35 and a 200 day moving average of $1.12. The company has a market cap of $11.62 million and a P/E ratio of -8.20.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Curanex Pharmaceuticals stock. Citadel Advisors LLC bought a new position in Curanex Pharmaceuticals Inc (NASDAQ:CURX) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 64,067 shares of the company’s stock, valued at approximately $46,000.

About Curanex Pharmaceuticals

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.